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Hydrogen sulfide: a new gaseous signal molecule and blood
pressure regulator
Abstract
The gas hydrogen sulfide (H2S) is emerging as a novel regulator of important physiologic functions
such as arterial diameter, blood flow and leukocyte adhesion. In addition, it may have antiinflammatory
and antiapoptotic effects. H2S has recently attracted much interest as a potent vasorelaxative substance
that may establish itself alongside another gaseous signal molecule, nitric oxide (NO). In contrast to NO,
the major source of H2S in blood may be production by red blood cells or by vascular smooth muscle
cells. H2S is produced from cysteine, involving the enzymes cystathionine beta-synthase and
cystathionine gamma-lyase (CSE). The importance of CSE was recently demonstrated in a mouse
lacking CSE which showed reduced H2S levels and developed hypertension and reduced
endothelium-mediated vasorelaxation. These data establish H2S as a new and important biologic signal
molecule and as a new regulator of vascular blood flow and blood pressure.
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Summary 
 
The gas hydrogen sulfide (H2S) emerges as a novel regulator of important 
physiologic functions such as arterial diameter, blood flow, or leukocyte adhesion. In 
addition, it may have anti-inflammatory and anti-apoptotic effects. H2S has attracted 
recently much interest as a potent vasorelaxative substance that may establish itself 
along with another gaseous signal molecule, nitric oxide (NO). In contrast to NO, the 
major source of H2S in blood may be production by red blood cells or by vascular 
smooth muscle cells. H2S is produced from cysteine involving the enzymes 
cystathionine β-synthetase (CBS) and cysthationine γ-lyase (CSE). The importance 
of CSE was recently demonstrated in a mouse lacking CSE which shows reduced 
H2S levels, develops hypertension, and reduced endothelium-mediated 
vasorelaxation. These data establish H2S as a new and important biologic signal 
molecule and as a new regulator vascular blood flow and blood pressure. 
 
 
Organ and cell function are orchestrated by a myriad of signal molecules that 
belong to virtually all classes of substances including lipids, small and large peptides, 
small organic and inorganic molecules (such as calcium, zinc, amino acids), and 
numerous intermediates from metabolism. Interestingly, also gaseous molecules play 
an important role as very short-lived, local, and often very potent signal molecules. 
Two major gaseous signalling molecules are well-known and much studied in 
humans, nitric oxide (NO) and carbon monoxide (CO). Particularly NO has attracted 
much attention since its discovery for its pleiotropic effects in cardiovascular biology, 
blood flow and pressure regulation or kidney function (1). The components of NO 
signalling include formation from arginine metabolism mediated by three different 
isoforms of NO synthase (endothelial, inducible, and neuronal), its targets such as 
guanylate cyclases, and degradative enzymes such as phosphodiesterases have 
been identified, and deranged regulation in disease states analyzed. Widely used 
drugs target exactly these mechanisms increasing thereby NO synthesis or the 
duration of its effects. The other important gas signal molecule, CO, is formed from 
heme by heme oxygenases and stimulates guanylate cyclases but with much lower 
potency than NO.   
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A third gaseous molecule has recently been implied in many physiologic functions 
including regulation of vascular tone, tissue survival under hypoxic conditions, or 
states similar to hibernation. These discoveries came as a surprise since H2S had 
been known only as a toxic gas and environmental pollutant. However, a number of 
recent exciting observations demonstrated beyond doubt that H2S is a physiologic 
gasotransmitter in its own right (for some recent reviews: (2-6)). The physiologic 
concentrations vary in different organs and solutions and values have been reported 
spanning a range from less than 1 nmol/g tissue to more than 100 nmol/g (4). 
 
 
What is the physiological source of H2S ? 
 
H2S is produced from sulphur-containing amino acids, methionine, cysteine, 
and cystine, catalyzed by two different enzymes, cystathionine β-synthetase (CBS) 
and cystathionine γ−lyase (CSE) (Figure 1). These enzymes are abundantly 
expressed in various organs, CBS is mainly expressed in the brain, peripheral 
nervous system, liver, and kidney, whereas CSE is mostly found in liver, vascular and 
non-vascular smooth cells. Moreover, small intestine and stomach express low 
amounts of CSE. A second source of H2S is the intestinal flora. Erythrocytes are a 
third source of H2S where H2S is produced from organic polysulfides in a glutathione-
dependent manner. Thus, there is ample local production of H2S enzymatically in 
arterial vessels both from smooth vascular cells in the arterial walls and non-
enzymatically from red blood cells. 
The enzymatic generation of H2S may be directly regulated by number of 
hormones and other signaling molecules. The activity of CBS is directly inhibited by 
two different gaseous signal molecules, NO and CO and stimulated by bacterial 
endotoxins. Also glucocorticoids appear to regulate CBS and CSE activity (2, 3). 
 
However, the biological importance of H2S in vivo and the contribution of CSE 
to total H2S generation and activity have remained open questions. A recent 
interesting report addressed these questions by genetic ablation of the cystathionine 
γ-lyase (CSE) enzyme in mice (7). 
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Cystathionine γ-lyase (CSE) produces H2S and regulates blood pressure 
 
Yang and colleagues produced mice lacking CSE (CSE KO) which had much 
lower H2S concentrations (50-80% reduction) in various tissues including aorta, 
smaller arteries, liver, and kidney. Also in serum, H2S levels were reduced by 50 %. 
CSE KO mice developed as early as 7 weeks after birth arterial hypertension with 
systolic blood pressure about 20 mm Hg higher (7). Since CBS is the major H2S-
producing enzyme in brain, endothelial NO-synthetase expression was unaltered, 
and because kidney structure was preserved in CSE KO mice, the authors assumed 
that it is the lack of H2S in peripheral arteries that caused hypertension. Indeed 
infusion of H2S acutely reduced blood pressure in normal mice. This blood pressure 
lowering response was much exaggerated in CSE KO mice.  
Homocysteine is a major precursor for H2S by CSE and the authors found 
highly elevated homocysteine levels in CSE deficient mice. Elevated homocysteine 
levels have been associated with higher blood pressure and cardiovascular disease 
even though this link has remained controversial. However, the authors increased 
homocysteine levels in normal mice by feeding methionine over 6 weeks which 
elevated homocysteine levels but did not affect blood pressure making it unlikely that 
homocysteine was responsible for hypertension in CSE deficient mice. 
The vascular role of H2S was further examined in isolated mesenteric arteries. 
Vasoconstriction evoked by phenylephrine was undistinguishable in arteries from 
normal and CSE KO mice. In contrast, the vasorelaxative effect of acetylcholine 
homologues was reduced. Since this effect depends on intact endothelial function, 
expression of CSE was investigated and found to be abundantly expressed in 
endothelial cells. Thus, it appears that vasorelaxation is influenced by H2S generated 
by endothelial CSE. Similarly, endothelial cells produce NO and the generation of NO 
by the endothelial NO synthetase (eNOS) is tightly regulated by calmodulin and 
inositol-1,4,5-trisphosphate (IP3) formation. Interestingly, CSE activity also seems to 
be directly regulated by calmodulin and increased intracellular calcium levels. 
Moreover, the authors demonstrate that CSE-dependent H2S formation is strongly 
stimulated by vasorelaxative hormones such as acetylcholine.  
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Is H2S part of the endothelium-derived –relaxing factor (EDRF) ? 
 
NO has been well established as an endothelial cell derived relaxing factor 
(EDRF) and experiments in mice lacking the endothelial isoform of NO synthetase 
(eNOS) have confirmed the importance of endothelial NO production in vivo and in 
vitro (8). However, these experiments also demonstrated that NO is not the only 
EDRF and that other EDRFs are produced and released from endothelium. The data 
reported by Yang et al. implicate H2S as part of the EDRF signal complex. H2S 
shares features with NO such as the acute regulation by vasorelaxative hormones 
through calmodulin and IP3 dependent pathways. Moreover, genetic ablation of H2S 
reduced the acetylcholine induced vasodilation by approximately 50-60 % in isolated 
mesenteric arteries indicating that H2S is major part of EDRF at least in this part of 
the arterial tree.  
 
 
Therapeutic implications 
 
Could H2S become a novel vasoactive therapeutic ? Apparently H2S has 
strong vasorelaxative and vasoprotective properties and might thus have similar 
beneficial properties like NO in states of local hypoperfusion. It remains to be 
determined if H2S might also be useful in treating arterial hypertension by decreasing 
peripheral resistance. Obviously not only clinical applications have to be examined 
but also the pharmacological properties of H2S liberating agents carefully studied. 
These agents might either act by stimulating endogenous H2S production through 
targeting the H2S producing enzymes CSE and CBS or by generating H2S from non-
enzymatic reactions such as occur in red blood cells. The latter may have the 
advantage that this way depends less on the expression levels of endogenous 
enzymes and the integrity of the endothelium. Moreover it remains to be seen if 
tachyphylaxis occurs with H2S as seen in patients treated with NO donors over longer 
periods. The isolation of H2S releasing and vasoactive substances from garlic (9) 
may serve as blueprint for such novel drugs.  
 
The discovery of H2S as a potent vasocative substance adds this gas to the 
growing list of interesting signal molecules. Together with NO and CO, H2S may 
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become the third important gaseous signal molecule and may have important roles in 
normal physiology as well as the development or treatment of disease states. For 
nephrologists and renal physiologists, the role of H2S in blood pressure regulation 
and the fact that the kidney expresses the highest levels of the H2S forming enzyme 
CSE may make this molecule an interesting and exciting new topic for research and 
future therapeutic approaches. 
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Figure legends 
 
Figure 1 
Simplified scheme of enzymatic and non-enzymatic H2S generation. H2S occurs 
through two major routes, enzymatically and non-enzymatically. Enzymatic 
generation of H2S involves synthesis of homocysteine from dietary methionine, 
subsequent formation of cystathionine and cysteine. Cysteine metabolism yields H2S. 
Several steps of this pathway are catalyzed by the enzymes cystathionine β-
synthetase (CBS) and cystathionine γ−lyase (CSE). A second pathway of H2S 
synthesis occurs mainly in red blood cells requiring glutathione (GSH) and generating 
oxidized glutathione (GSSG). H2S can be inactivated by degradation to thiosulphates 
or reacts with proteins 
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